Extramedullary hematopoiesis secondary to malignant solid tumors: a case report and literature review

Youting Bao, Zhichao Liu, Meiying Guo, +3

Cancer Management and Research

Esophageal CancerHealth SciencesLiterature ReviewMedicineSurgical Pathology +13

Prognostic Value of Dynamic Albumin-to-Alkaline Phosphatase Ratio in Limited Stage Small-Cell Lung Cancer

Xiaogang Li, Butuo Li, Haiyan Zeng, +5

Future Oncology

Development and validation of a nomogram prognostic model for esophageal cancer patients with oligometastases

Butuo Li, Ruiqing Wang, Ting Zhang, +9

Scientific Reports

Oligometastatic Ec PatientsEsophageal Cancer PatientsEsophagusEsophageal CancerMedicine +11

Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using <scp>MR</scp> images

Tianyu Jiao, Fuyan Li, Yi Cui, +6

Journal of Magnetic Resonance Imaging

Adebrelimab plus chemotherapy and sequential thoracic radiotherapy as first-line therapy for extensive-stage small–cell lung cancer (ES-SCLC): a phase II trial

Dawei Chen, Bing Zou, Butuo Li, +15

EClinicalMedicine

First-line TherapySequential Thoracic RadiotherapyPhase Ii TrialRadiation TherapyMedicine +4

The Kinetic Changes of Systemic Inflammatory Factors during Bevacizumab Treatment and Its Prognostic Role in Advanced Non-small Cell Lung Cancer Patients

Butuo Li, Shijiang Wang, Cheng Li, +5

Journal of Cancer

Prognostic value of delta inflammatory biomarker-based nomograms in patients with inoperable locally advanced NSCLC

Meiying Guo, Wanlong Li, Butuo Li, +6

International Immunopharmacology

InflammationAdvanced NsclcPrognostic BiomarkersBiomarker (Medicine)Prognostic Value +5

Predictive value of LDH kinetics in bevacizumab treatment and survival of patients with advanced NSCLC

Butuo Li, Cheng Li, Meiying Guo, +6

OncoTargets and Therapy

From pixels to patient care: deep learning-enabled pathomics signature offers precise outcome predictions for immunotherapy in esophageal squamous cell cancer

Butuo Li, Wenru Qin, Linlin Yang, +8

Journal of Translational Medicine

Clinical implications of germline BCL2L11 deletion polymorphism in pretreated advanced NSCLC patients with osimertinib therapy

Xuanzong Li, Dai Zhang, Butuo Li, +6

Lung Cancer

Clinical ImplicationsGenetic DisorderGenetic EpidemiologyHuman PolymorphismPathology +7